跳至主要内容
临床试验/NCT06963372
NCT06963372已完成不适用

Assessment of Health Effects of Air Purifier Interventions on Chronic Kidney Disease Patients

Inha University Hospital1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2022年4月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
IL-6 in pg/mL

研究概览

简要总结

This exploratory study investigates the impact of indoor air quality improvement via air purifiers on the health of chronic kidney disease (CKD) patients.

A randomized, single-blind, crossover study with 24 CKD patients and 24 healthy controls was conducted at two hospitals. Participants used either a true filter or a sham filter in air purifiers for four weeks each, with a two-week washout period. True filters significantly reduced indoor PM2.5 levels compared to sham filters. Higher indoor PM2.5 levels were associated with increased cytokines (IL-1beta, IL-6, IL-8/CXCL8) and decreased hemoglobin, with ESR and PWV showing an increasing trend, particularly in CKD patients. True filters significantly reduced IL-1beta and IL-8/CXCL8 levels, with a borderline significant reduction in ABI. The study confirmed limited but notable effects of air purifiers on reducing PM2.5 and improving some health markers in CKD patients.

详细描述

Objectives:

Recent research has demonstrated that increasing levels of fine particulate matter (PM2.5) are associated with reduced glomerular filtration rates and elevated risks of chronic kidney disease (CKD) and end-stage renal disease (ESRD). To mitigate health impacts from PM2.5 exposure, recommendations include limiting outdoor activities, using air purifiers to improve indoor air quality, and wearing protective masks when outdoors. However, scientific evidence on the effectiveness of these interventions remains insufficient, particularly concerning how PM2.5 mitigation affects CKD progression. Therefore, this exploratory study aims to evaluate the impact of indoor air quality improvement via air purifiers on the health of CKD patients.

Methods:

A randomized, single-blind, crossover study was conducted at two university hospitals in Seoul and Incheon, involving 24 CKD patients and 24 healthy controls. Participants underwent two repeated measures with each receiving either a true filter or a sham filter in air purifiers for four weeks, separated by a two-week washout period. The sequence of filter application was counterbalanced between two groups. Data collection included surveys on lifestyle, medical history, and living environment, as well as blood, urine, and vascular endothelial function tests. The relationship between air purifier usage and health outcomes was analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patient Group: Patients aged 20 years or older with stage 3 or higher chronic kidney disease (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m²).
  • •Control Group: Individuals aged 20 years or older who have not been told of any kidney function abnormalities based on blood tests within the past year and have never been diagnosed with chronic kidney disease. Baseline labs will be conducted, and only those with an eGFR ≥60 mL/min/1.73 m² will be enrolled. This group includes household members of the patient group or other healthy individuals.
  • •Individuals who are not currently using a household air purifier.
  • •Individuals who have consented to participate in the clinical study.

排除标准

  • •Patients with stage 5 chronic kidney disease.
  • •Individuals with a history of chronic obstructive pulmonary disease (COPD), asthma, allergy, cerebrovascular accident (CVA), malignancy (cancer), cardiovascular interventions, or those with an active infection.
  • •Individuals taking immunosuppressive medications.
  • •Patients with diabetes or hypertension whose blood sugar and blood pressure are uncontrolled (HbA1c > 8%, office SBP > 150 mmHg).

研究组 & 干预措施

Group A

Experimental

Group A used an air purifier equipped with a true filter for four weeks, followed by a two-week washout period, and then used an air purifier with a sham filter.

干预措施: True filter (4w) → Washout (2w) → Sham filter (4w) (Device)

Group B

Experimental

Group B used an air purifier equipped with a sham filter for four weeks, followed by a two-week washout period, and then used an air purifier with a true filter.

干预措施: Sham filter (4w) → Washout (2w) → True filter (4w) (Device)

结局指标

主要结局

IL-6 in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

IL-1beta in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

IL-8/CXCL8 in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

IL-10 in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

IFN-gamma in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

TNF-alpha in pg/mL

时间窗: 0 weeks, 4 weeks, 6 weeks, 10 weeks

Blood samples were collected to analyze cytokines.

次要结局

  • Bood pressure (Systolic) in mmHg(0 weeks, 4 weeks, 6 weeks, 10 weeks)
  • Bood pressure (Diastolic) in mmHg(0 weeks, 4 weeks, 6 weeks, 10 weeks)
  • Pulse Wave Velocity in m/sec(0 weeks, 4 weeks, 6 weeks, 10 weeks)
  • Ankle-Brachial Pressure Index(0 weeks, 4 weeks, 6 weeks, 10 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hwan-Cheol Kim

Professor

Inha University Hospital

研究点 (1)

Loading locations...

相似试验